natgillin/translations-raw huggingface dataset:
Pergoveris erstatter de manglende hormoner og giver derved kvinder med mangel på FSH og LH mulighed for at danne en follikel, der kan udløse et æg efter injektion af hormonet humant koriongonadotropin (hCG).
By replacing the missing hormones, Pergoveris allows women with FSH and LH deficiency to develop a follicle, which will release an egg after an injection of the hormone human chorionic gonadotrophin (hCG).
Pergoveris findes som pulver og solvens til injektionsvæske, opløsning.
Pergoveris is presented as a powder and solvent for solution for injection.
Pergoveris follitropin alfa/lutropin alfa
Pergoveris follitropin alfa / lutropin alfa
Pergoveris indeholder mindre end 1 mmol (23 mg) natrium pr. dosis, dvs. den er i det væsentlige natriumfri.
Pergoveris contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially “sodium-free”.
Pergoveris leveres i pakninger indeholdende 1, 3 og 10 hætteglas med pulver sammen med et tilsvarende antal solvens hætteglas (1, 3 og 10).
Pergoveris is supplied in packs of 1, 3 and 10 vials of powder with the corresponding number of solvent’s vials (1, 3 and 10 vials).
Pergoveris-behandling fører sjældent til alvorlig OHSS.
Pergoveris treatment seldom causes severe OHSS.
Pergoveris’ sikkerhed og virkning hos ældre patienter er ikke klarlagt.
Safety and effectiveness of Pergoveris in elderly patients have not been established.
Peri- og postnatal udvikling
Peri- and Post-Natal Development
pericarditis, atrioventrikulært blok
pericarditis, atrioventricular block
perifer
+left
perifer
peripheral
perifer arteriel okklusionssygdom, perifer iskæmi, perifer arteriestenose, claudicatio intermittens, dyb venetrombose, hedeture, rødmen
peripheral arterial occlusive disease, peripheral ischaemia, peripheral artery stenosis, intermittent claudication, deep vein thrombosis, hot flush, flushing
Perifer emboli, lymfødem, bleghed, erythromelalgi, vasodilatation, misfarvning af vener, veneinsufficiens
Peripheral embolism, Lymphoedema, Pallor, Erythromelalgia, Vasodilatation, Vein discolouration, Venous insufficiency
Perifer hævelse
Peripheral swelling
Perifer iskæ mi, tromboflebitis, hæ matom.
Peripheral ischaemia, thrombophlebitis, haematoma.
Perifer iskæmi, hypotension§
Peripheral ischaemia, hypotension§
Perifer iskæmi٭
Peripheral ischaemia
Perifer kuldefornemme lse
peripheral coldness
Perifer kuldefølelse Smerte på infusionsstedet Reaktion på infusionsstedet
Chest discomfort Irritability Peripheral coldness Infusion site pain Infusion site reaction
Perifer motorisk neuropati
Peripheral motor neuropathy
Perifer motorisk neuropati (G3/4: 0 %)
Headache (G3/4: <1%); Neuropathy peripheral
Perifer motorisk neuropati (G3/4: 0 %)
Peripheral motor neuropathy (G3/4: 0%);
Perifer motorisk neuropati (G3/4: 0 %);
Peripheral motor neuropathy (G3/4: 0%)
Perifer motorisk neuropati (G3/4: 0%)
Peripheral motor neuropathy (G3/4: 0%);
Perifer motorisk neuropati af grad 2
Grade 2 peripheral motor neuropathy
Perifer neuropati (eksklusive
Deafness (Including Hypoacusis), Tinnitus
Perifer neuropati (eksklusive motorisk neuropati), svimmelhed, tremor, dysgeusi, hovedpine Almindelig
Peripheral neuropathies (excluding motor neuropathy), Dizziness, Tremor, Dysgeusia, Headache
Perifer neuropati (polyradiculitis, facialisparase), optisk neurit, centralnervesystems-demyelinisering (multipel sklerose) er indberettet efter administration af vaccine, der indeholder et hepatitis B antigen.
Peripheral neuropathy (polyradiculoneuritis, facial paralysis), optic neuritis, central nervous system demyelination (multiple sclerosis) have been reported after administration of a hepatitis B antigen containing vaccine
Perifer neuropati blev indberettet hos 16,5 % af patienterne i placebogruppen og hos 19,1 % af patienterne i nintedanib- gruppen.
Peripheral neuropathy was reported in 16.5 % of patients in the placebo arm and in 19.1 % of patients in the nintedanib arm.
Perifer neuropati er rapporteret hos patienter i behandling med Leflunomid Winthrop.
Cases of peripheral neuropathy have been reported in patients receiving leflunomide.
Perifer neuropati Hovedpine† Smagsforstyrrelser
Neuropathy peripheral Headache † Dysgeusia
Perifer neuropati inkluderede de foretrukne termer: perifer sensorisk neuropati, perifer neuropati, perifer motorisk neuropati og perifer sensomotorisk neuropati
Peripheral neuropathy included the preferred terms: peripheral sensory neuropathy, neuropathy peripheral, peripheral motor neuropathy, and peripheral sensorimotor neuropathy
Perifer neuropati kan forekomme efter det første behandlingsforløb og forværres med øgende eksponering overfor paclitaxel.
Peripheral neuropathy can occur following the first course and can worsen with increasing exposure to paclitaxel.
perifer neuropati neuropathy, hypæstesi, dysgeusi, tremor
peripheral neuropathy, hypoaesthesia, dysgeusia, tremor
Perifer neuropati samt optisk neuropati, der i nogle tilfælde udviklede sig til synstab, er rapporteret hos patienter, der blev behandlet med et andet antibiotikum i oxazolidinon-klassen over en periode, der var længere end den behandlingsperiode, der anbefales for Sivextro.
Peripheral neuropathy, as well as optic neuropathy sometimes progressing to loss of vision, have been reported in patients treated with another member of the oxazolidinone class with treatment durations exceeding that recommended for Sivextro.
Perifer neuropati ≥ grad 3 forekom hos 6% af patienterne i den subkutane behandlingsgruppe sammenlignet med 16% i den intravenøse behandlings- gruppe (p=0,0264).
Grade ≥ 3 peripheral neuropathy occurred in 6% of patients in the subcutaneous treatment group, compared with 16% in the intravenous treatment group (p=0.0264).
Perifer neuropati  grad 3 forekom hos 6 % af patienterne i den subkutane behandlingsgruppe sammenlignet med 16 % i den intravenøse behandlingsgruppe (p=0,0264).
Grade ≥ 3 peripheral neuropathy occurred in 6% of patients in the subcutaneous treatment group, compared with 16% in the intravenous treatment group (p=0.0264).
Perifer neuropati*, cognitive forstyrrelser, hyperæstesi, apati, tab af bevidsthed, svækkelse, neuralgi, præsynkope
Neuropathy peripheral*, cognitive disorder, hyperaesthesia, lethargy, loss of consciousness, mental impairment, neuralgia, presyncope
Perifer neuropati, ataksi, amnesi, paræstesi, hypæstesi, hovedpine, svimmelhed
Common Peripheral neuropathy, ataxia, amnesia, paraesthesia, hypoaesthesia, headache, dizziness
Perifer neuropati, hovedpine
Neuropathy peripheral, Headache
perifer neuropati, hovedpine, svimmelhed
peripheral neuropathy, headache, dizziness
Perifer neuropati, hovedsageligt grad 1 eller 2, forekom hos 12,3 % af patienterne, som fik Pom + LD-Dex, og hos 10,7 % af patienterne, som fik HD-Dex.
Peripheral neuropathy, mostly Grade 1 or 2 occurred in 12.3% patients who received Pom + LD-Dex, and 10.7% of patients who received HD-Dex.
perifer neuropati, hypæstesi, dysgeusi, tremor
peripheral neuropathy, hypoaesthesia, dysgeusia, tremor
Perifer neuropati, karakteriseret ved parestesi/dysestesi, er en almindelig og velkendt effekt af arsen i miljøet.
Peripheral neuropathy, characterised by paresthesia/dysesthesia, is a common and well known effect of environmental arsenic.
perifer neuropati, paræstesi, ageusi, tremor
peripheral neuropathy, paraesthesia, ageusia, tremor
Perifer neuropati, primært grad 1 og hyppigst sensorisk, er indberettet i kliniske studier med trastuzumabemtansin.
Peripheral neuropathy, mainly Grade 1 and predominantly sensory, has been reported in clinical studies with trastuzumab emtansine.
perifer neuropati, svimmelhed
peripheral neuropathy, dizziness
perifer neuropati, synkope, amnesi
peripheral neuropathy, syncope, amnesia
Perifer neuropati2, paræstesi2
peripheral neuropathy2, paraesthesia2
Perifer neuropati: Hvis der opstår symptomer på perifer neuropati (sædvanligvis karakteriseret ved vedvarende følelsesløshed, prikken eller smerte i fødder og/eller hænder) (se pkt 4.4), skal patienterne skiftes til andet behandlingsregime, såfremt dette er passende.
Peripheral neuropathy: if symptoms of peripheral neuropathy develop (usually characterised by persistent numbness, tingling, or pain in the feet and/or hands) (see section 4.4) patients should be switched to an alternative treatment regimen, if appropriate.
Perifer neuropatic (35,9 %) (G3/4: 7,3 %)
Peripheral neuropathyc (35.9%) (G3/4: 7.3%)
Perifer sensorisk neuropati (G3/4:
Peripheral sensory neuropathy (G3/4:
Perifer sensorisk neuropati (G3/4:
Peripheral sensory neuropathy (G3/4: 1.2%);
Perifer sensorisk neuropati (G3/4: 0,1 %)
Peripheral sensory neuropathy (G3/4: <0.1%)
Perifer sensorisk neuropati (G3/4: 0,8%)
Peripheral sensory neuropathy (G3/4: 0.8%)
Perifer sensorisk neuropati (G3/4: 1,2 %);
Dysgeusia (G3/4: 0.6%); Peripheral sensory neuropathy (G3/4: 0.1%)
Perifer sensorisk neuropati (G3/4: 1,2 %);
Hot flush (G3/4: 0.5%)
Perifer sensorisk neuropati (G3/4: 1,2 %); dysgeusi (G3/4: 0 %)
Peripheral sensory neuropathy (G3/4: 1.2%); Dysgeusia (G3/4: 0%)
Perifer sensorisk neuropati (G3/4: 1,2%)
Peripheral sensory neuropathy (G3/4: 1.2%)
Perifer sensorisk neuropati (G3/4: 1,2%);
Peripheral sensory neuropathy (G3/4: 1.2%);
Perifer sensorisk neuropati (G3/4: 8,7 %)
Dysgeusia/Parosmia; Peripheral sensory neuropathy (G3/4: 0.6%)
Perifer sensorisk neuropati (G3/4: 8,7%)
Peripheral sensory neuropathy (G3/4: 8.7%)
Perifer sensorisk neuropati (G3: 3,7 %); Perifer motorisk neuropati (G3/4: 2 %)
Paresthesia; Headache; Dysgeusia; Hypoaesthesia
Perifer sensorisk neuropati (G3: 3,7 %); Perifer motorisk neuropati (G3/4: 2 %)
Peripheral sensory neuropathy (G3: 3.7%) Peripheral motor neuropathy (G3/4: 2%)
Perifer sensorisk neuropati (G3: 4,1 %); Perifer motorisk neuropati (G3/4: 4 %) Dysgeusi (alvorlig: 0,07 %)
Peripheral sensory neuropathy (G3: 4.1%); Peripheral motor
Perifer sensorisk neuropati (G3: 4,1 %); Perifer motorisk neuropati (G3/4: 4 %) Dysgeusi (alvorlig: 0,07 %)
Peripheral sensory neuropathy (G3: 4.1%); Peripheral motor neuropathy (G3/4: 4%);
Perifer sensorisk neuropati (G3: 4,1 %); Perifer motorisk neuropati (G3/4: 4 %) Dysgeusi (alvorlig: 0,07 %)
Peripheral sensory neuropathy (G3: 4.1%); Peripheral motor neuropathy (G3/4: 4%); Dysgeusia (severe 0.07%)
Perifer sensorisk neuropati (G3: 4,1 %); Perifer motorisk neuropati (G3/4: 4 %) Dysgeusi (alvorlig: 0,07 %)
Peripheral sensory neuropathy (G3: 4.1%); Peripheral motor neuropathy (G3/4: 4%); Dysgeusia (severe:
Perifer sensorisk neuropati (G3: 4,1 %); Perifer motorisk neuropati (G3/4: 4 %) Dysgeusi (alvorlig: 0,07 %)
Peripheral sensory neuropathy (G3: 4.1%); Peripheral motor neuropathy (G3/4: 4%); Dysgeusia (severe: 0.07%)
Perifer sensorisk neuropati (G3: 4,1 %); Perifer motorisk neuropati (G3/4: 4 %); Dysgeusi (alvorlig: 0,07 %)
Peripheral sensory neuropathy (G3: 4.1%); Peripheral motor neuropathy (G3/4: 4%); Dysgeusia (severe: 0.07%)
Perifer sensorisk neuropati (G3: 4,1%); Perifer motorisk neuropati (G3/4: 4%); Dysgeusi (alvorlig: 0,07%)
Peripheral sensory neuropathy (G3: 4.1%); Peripheral motor neuropathy (G3/4: 4%); Dysgeusia (severe: 0.07%)
Perifer sensorisk neuropati fortsatte under opfølgning hos 10 patienter ud af 84 patienter med perifer sensorisk neuropati ved slutningen af kemoterapien i det lymfeknude-positive brystkræft-studie (TAX 316).
Peripheral sensory neuropathy was observed to be ongoing during follow-up in 10 patients out of the 84 patients with peripheral sensory neuropathy at the end of the chemotherapy in the node positive breast cancer study (TAX316).
Perifer sensorisk neuropati fortsatte under opfølgning hos 10 patienter ud af 84 patienter med perifer sensorisk neuropati ved slutningen af kemoterapien i det lymfeknude-positive brystkræft-studie (TAX 316).
Peripheral sensory neuropathy was observed to be ongoing during follow-up in10 patients out of the 84 patients with peripheral sensory neuropathy at the end of the chemotherapy in the node positive breast cancer study (TAX316).
Perifer sensorisk neuropati fortsatte under opfølgning hos 10 patienter ud af 84 patienter med perifersensorisk neuropati ved slutningen af kemoterapien i det lymfeknude-positive brystkræft-studie (TAX316).
Peripheral sensory neuropathy was observed to be ongoing during follow-up in 10 patients out of the 84 patients with peripheral sensory neuropathy at the end of the chemotherapy in the node positive breast cancer study (TAX316).
Perifer sensorisk neuropati fortsatte under opfølgning hos 10 patienter ud af 84 patienter med perifersensorisk neuropati ved slutningen af kemoterapien i det lymfeknude-positive brystkræftstudie (TAX 316).
Peripheral sensory neuropathy was observed to be ongoing during follow-up in 10 patients out of the 84 patients with peripheral sensory neuropathy at the end of the chemotherapy in the node positive breast cancer study (TAX316).
Perifer sensorisk neuropati Svimmelhed
Peripheral sensory neuropathy Dizziness
Perifer sensorisk neuropati, dysgeusi, svimmelhed, paræstesi
Peripheral sensory neuropathy, Dysgeusia, Dizziness, Paraesthesia
Perifer sensorisk neuropati, dysæstesi*, neuralgi*
Peripheral sensory neuropathy, Dysaesthesia*, Neuralgia
Perifer sensorisk neuropati, letargi
Peripheral sensory neuropathy, Lethargy
perifer sensorisk neuropati, svimmelhed, hovedpine, sløvhed
peripheral sensory neuropathy, dizziness, headache, lethargy
Perifer vaskulær sygdom (herunder vaskulitis)
Peripheral vascular disorder (including vasculitis)
Perifer ødem
Peripheral oedema
perifere diabetiske neuropatiske smerter (smerter forårsaget af sukkersygebetingede nervelidelser i arme og ben). generaliseret angst (langvarig angst eller ængstelighed over for hverdagens begivenheder).
pain due to diabetic peripheral neuropathy (damage to the nerves in the extremities that can occur in patients with diabetes); generalised anxiety disorder (long-term anxiety or nervousness about everyday matters).
Perifere diabetiske neuropatiske smerter:
Diabetic peripheral neuropathic pain
Perifere mononukleæ re blodceller (PBMC) fra patienter behandlet med infliximab udviste usvæ kket proliferativ reaktion på stimuli sammenlignet med patienter, der ikke var behandlet, og der konstateredes ingen væ sentlige æ ndringer i cytokinproduktion hos stimuleret PBMC efter behandling med infliximab.
Peripheral blood mononuclear cells (PBMC) from infliximab-treated patients showed undiminished proliferative responsiveness to stimuli compared with untreated patients, and no substantial changes in cytokine production by stimulated PBMC were observed following treatment with infliximab.
perifere neurologiske symptomer inklusive perifer neuropati, paræstesier og perifer neuritis (følelsesløshed, svaghed, prikken eller smerter i arme og ben)
peripheral neurologic symptoms including peripheral neuropathy, paresthesia, and peripheral neuritis (numbness, weakness, tingling or pain in the arms and legs)
perifere neuropatier, svimmelhed, tremor
peripheral neuropathies, dizziness, tremor
Perifere og centrale neuropatiske smerter: Pregabalin Mylan Pharma anvendes til behandling af langvarige smerter, som skyldes beskadigede nervebaner.
Peripheral and central neuropathic pain: Pregabalin Mylan Pharma is used to treat long lasting pain caused by damage to the nerves.
Perifere ødemer
Influenza-like symptoms
Perifere ødemer Forstoppelse
Oedema peripheral Constipation
Perifere ødemer Obstipation
Oedema peripheral Constipation
Perifere ødemer Reaktioner på injektionsstedet
Oedema peripheral Injection site reaction
Perifere ødemer*
Oedema periphera l
Perifere ødemer*
Oedema peripheral
Perifere ødemer*
periphera l
Perifere ødemer, Utilpashed, Brystsmerter
erythema, Swelling
Perifere ødemer, Utilpashed, Brystsmerter
Malaise, Chest
Perifere ødemer, ødem, gangforstyrrelser, faldtendens, følelse af beruselse, føle sig unormal, træthed
Common Oedema peripheral, oedema, gait abnormal, fall, feeling drunk, feeling abnormal, fatigue
Perifert ødem
disorders
Perifert ødem
Hypersensitivity-type
Perifert ødem
Peripheral oedema
Perifert ødem (G3/4: 0,2 %)
Pyrexia (G3/4: NA); Oedema peripheral (G3/4: 0.2%)
Perifert ødem (væskeophobning i arme og ben)
Oedema peripheral (dropsy in extremities)
Perifert ødem Almindelig
Peripheral oedema Common
Perifert ødem Slimhindeødem
Oedema peripheral Oedema mucosal
Perifert ødem Træthed Asteni Abstinens- syndrom Kulderystelser
Peripheral oedema Fatigue Asthenia Drug withdrawal syndrome Chills
perifert ødem, abnorm smag af lægemidlet
oedema peripheral, product taste abnormal
Perifert ødem, asteniske tilstandea (inkl. træthed, asteni, utilpashed)
Oedema peripheral, asthenic conditionsa (incl. fatigue, asthenia, malaise)
Perifert ødem, kulderystelser, influenza- lignende sygdom, utilpashed, hypertermi
Peripheral oedema, chills, influenza-like illness, malaise, hyperthermia
Perifert ødem, overfølsomheds- reaktioner
Peripheral oedema, Hypersensitivity reactions
Perifert ødem, overfølsomheds- reaktioner, reaktioner på administrationsstedet
Peripheral oedema Hypersensitivity reaction, Injection site reaction
perifert ødem, pyreksi
oedema peripheral, pyrexia
Perifert ødem, tørst, akut-fase reaktion, ikke-kardielle brystsmerter
Peripheral oedema, thirst, acute phase reaction, non-cardiac chest pain
Perifert ødem, væskeretention
Peripheral oedema, fluid retention
Perifert ødem2 Ikke almindelig
Peripheral oedema2 Uncommon
Perifert ødem3
Oedema peripheral3
Perifert ødem;^ utilpashed; asteni
Oedema peripheral;^ Malaise; Asthenia
perifert ødemg, udmattelse, pyreksi, ansigtsødemh
peripheral oedemag, fatigue, pyrexia, face oedemah
perifert, hævelse),
peripheral, swelling),
Perifær ødem
peripheral oedema
Perikardial blødning
Pericardial haemorrhage
Perikardial effusion*, perikarditis*
Pericardial effusion*, pericarditis
Perikardial effusion٭, perikarditis٭
Pericardial effusion*, pericarditis
perikardial ekssudation
pericardial effusion
Perikardie- effusion
Hepatic failure
Perikardie- effusion
Pericardial effusion
Perikardie-effusion
Pericardial effusion
Perikardie-effusion٭, perikarditis٭
Pericardial effusion*, pericarditis
perikardiee
pericardial effusion
Perikardiel effusion
Eye haemorrhage
Perikardit*, hjertetamponade*
Pericarditis*, cardiac tamponade
perikarditis (betændelse i hjertesækken), perikardial effusion [en væskeansamling, der udvikles mellem perikardium (hjertesækken) og selve hjertet] ændring i tungens farve.
pericarditis (inflammation of the lining of the heart), pericardial effusion [a fluid collection that develops between the pericardium (the lining of the heart) and the heart itself, change in colour of the tongue.
perikarditis (betændelse i hjertesækken), perikardial effusion [en væskeansamling, der udvikles mellem perikardium (hjertesækken) og selve hjertet].
mania (excessive or unreasonable enthusiasm), pericarditis (inflammation of the lining of the heart), pericardial effusion [a fluid collection that develops between the pericardium (the lining of the heart) and the heart itself.
perikarditis (betændelse i hjertesækken), perikardial effusion [en væskeansamling, der udvikles mellem perikardium (hjertesækken) og selve hjertet]. ændring i tungens farve.
pericarditis (inflammation of the lining of the heart), pericardial effusion [a fluid collection that develops between the pericardium (the lining of the heart) and the heart itself, change in colour of the tongue.
Perikarditisb
Pericarditisb
perikon
perforatum)
Perikon
St John's Wort
Perikon
St John’s wort
Perikon
St. John's Wort
Perikon
St. John’s Wort
perikon
Wort
Perikon (Hypericum
Interaction
Perikon (Hypericum
St. John’s wort (Hypericum
Perikon (Hypericum
St. John’s wort (Hypericum perforatum)
Perikon (Hypericum perforatum – et naturlægemiddel, der anvendes mod depression)
St. John’s wort (Hypericum perforatum – herbal medicine used to treat depression);
Perikon (Hypericum perforatum – et naturlægemiddel, der anvendes til at behandle depression)
St. John’s wort (Hypericum perforatum – herbal medicine used to treat depression);
Perikon (Hypericum perforatum)
concentration monitoring is
Perikon (Hypericum perforatum)
Not studied.
Perikon (Hypericum perforatum)
St John’s wort (Hypericum perforatum)
Perikon (Hypericum perforatum)
St. John’s wort
Perikon (Hypericum perforatum)
St. John’s wort (Hypericum perforatum)
Perikon (Hypericum perforatum) (et naturlægemiddel mod depression).
St John’s wort (hypericum perforatum) (a medicine to treat depression).
Perikon (Hypericum perforatum) (et naturlægemiddel mod depression).
St John’s wort (hypericum perforatum)(a medicine to treat depression).
Perikon (Hypericum perforatum) (naturlægemiddel mod depression og angst)
St. John’s wort (Hypericum perforatum) (a herbal preparation used for depression and anxiety)
Perikon (Hypericum perforatum) eller naturlægemidler, som indeholder dette (bruges mod depression eller angst).
St John's wort (Hypericum perforatum) or herbal medicines that contain it (used for depression or anxiety).
Perikon (Hypericum perforatum) – et naturlægemiddel, der bruges mod depression.
St. John’s wort (Hypericum perforatum) – an herbal medicine used for depression.
perikon (Hypericum perforatum), naturmedicin, som bruges mod depression eller andre lidelser
St. John’s Wort (Hypericum perforatum), used for depression or other conditions oral antidiabetics
Perikon (Hypericum perforatum), som er et naturlægemiddel mod depression.
St. John’s wort (Hypericum perforatum), a herbal medicine to treat depression.
Perikon (Hypericum perforatum).
St. John’s wort (Hypericum perforatum).
Perikon (Hypericum perforatum): Samtidig administration af Atripla og perikon eller naturlægemidler, der indeholder perikon, er kontraindiceret.
St. John’s wort (Hypericum perforatum): Co-administration of Atripla and St. John’s wort or herbal preparations containing St. John’s wort is contraindicated.
Perikon (Hypericum perforatum,
St John’s wort (Hypericum perforatum, a herbal medicine)
perikon (Hypericum perforatum, naturlægemiddel til behandling af depression)
St John’s Wort (Hypericum perforatum, medicine to treat depression)
Perikon (Hypericum perforatum, naturlægemiddel til behandling af depression)
St. John’s Wort (Hypericum perforatum, medicine to treat depression)
perikon (naturlægemiddel mod depression)
St. John's wort (a herbal medicine used to treat depression)
perikon (naturlægemiddel mod depression)
St. John’s wort (an herbal medicine to treat depression)
Perikon (naturlægemiddel).
St John’s wort (herbal medicine).
Perikon (naturmedicin)
St John’s Wort (herbal supplement)
Perikon (naturmedicin)
St. John’s Wort (herbal supplement)
Perikon (naturmedicin).
St John’s Wort (herbal supplement)
Perikon (naturmedicin).
St. John’s Wort (herbal supplement)
perikon - et naturlægemiddel mod depression
St John’s wort (a herbal medicine for depression)
Perikon er et naturlægemiddel, som du kan få i håndkøb.
St John’s wort is often used in herbal medicines that you can buy yourself.
Perikon forventes at nedsætte plasmakoncentrationen af darunavir eller dets farmakoforstærkere. (CYP-induktion)
St John’s wort is expected to decrease the plasma concentrations of darunavir or its pharmacoenhancers. (CYP450 induction)
Perikon forventes at nedsætte plasmakoncentrationen af darunavir og ritonavir.
St John’s wort is expected to decrease the plasma concentrations of darunavir and ritonavir.
Perikon forventes at reducere plasmakoncentrationen af etravirin.
St John’s wort is expected to decrease the plasma concentrations of etravirine.
perikon kan ikke tilrådes.
recommended.
perikon kan vedvare i mindst
John’s wort may persist for at least 2
perikon må ikke anvendes samtidig
John’s wort must not be combined
perikon – naturlægemiddel mod depression, rifampicin – mod tuberkulose.
St John’s Wort - a herbal medicine for depression, rifampicin - for tuberculosis.
perikon – naturmedicin, der bruges til at behandle depression
St John’s Wort – a herb extract used to treat depression
perikon, et naturlægemiddel som bruges mod depression
St. John´s wort, a herbal medicine for depression
Perikon/dolutegravir
St. John’s wort/Dolutegravir
perikon: naturmedicin, der bruges til at behandle depression
St. John’s wort: a herbal product used to treat depression.
perikon;
St. John’s wort;
PerikonPerikon (Hypericum perforatum)
St John’s wort (Hypericum perforatum)
perikons
induction by